
BioTech Quell Therapeutics’ Series A financing hits £60m
A Treg cell therapeutics BioTech has grown its Series A financing to more than £60 million. ...
A Treg cell therapeutics BioTech has grown its Series A financing to more than £60 million. ...
A Cambridge University programme has produced a fleet of the UK’s ‘next generation’ entreprene...
A listed radiation tech firm which is to run COVID-19 detection pilots in airports and hospitals i...
A company which connects critical life-saving data to first responders within the emergency servic...
Immunocore’s flotation in the US has raised $258 million. The pricing of its initial ...
Digital triage firm eConsult Health has attracted £7 million in new investment. With consid...
Vamstar has raised £1.25 million to expand its AI-powered B2B healthcare marketplace. Th...
Listed Cambridge tech firm Checkit has acquired its US distributor after revealing it is supporti...
The tech start-up behind an AI-powered fitness device has been backed financially by tennis star J...
Octopus Ventures is planning a new £100 million global fund to invest in early-stage HealthTech c...
12 noon-1pm - GoToWebinar event with Biramis 25/03/2021
12 noon-1pm - GoToWebinar event with Biramis 29/04/2021
Demystifying Tech: How does Open Banking work? In this week's show host Alistair Hardaker is join...
Demystifying Tech: Is your sports team in breach of GDPR? Could your local sports team in breach ...
Demystifying Tech: What exactly is a 'smart city? In this week's show we're talking folding phone...
Demystifying Tech: The new tech at Abbey Road Studios In this week's show host Alistair Hardaker ...
On the eve of International Women’s Day, BusinessCloud executive editor Chris Maguire says mo...
By Paige Erickson, MD EMEA, Workfront (an Adobe company) There is no doubt that the way...
By Johan Hajji, co-founder, UpperKey With lockdowns still in place across Europe, rental...
By Richard Hibbert, CEO at SureCloud According to a report released by the UN, phishing ...